Ionis Pharmaceuticals, Inc.
IONS · NASDAQ
10/28/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$128,606 | $123,551 | -$146,938 | -$104,349 |
| Dep. & Amort. | $11,851 | $5,454 | $4,815,000 | $5,267 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $31,146 | $29,690 | $29,718 | $36,148 |
| Change in WC | $69,658 | -$28,483 | -$41,175 | -$61,385 |
| Other Non-Cash | -$115,486 | $21,126 | -$4,807,380 | $8,180 |
| Operating Cash Flow | -$131,437 | $151,338 | -$150,775 | -$116,139 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,270 | -$12,305 | -$12,577 | -$25,497 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$323,938 | -$491,589 | -$311,068 | -$333,631 |
| Inv. Sales/Matur. | $422,206 | $385,790 | $494,755 | $429,888 |
| Other Inv. Act. | -$1,660 | -$1,964 | -$651 | -$2,547 |
| Investing Cash Flow | $91,338 | -$120,068 | $170,459 | $68,213 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$41 | -$40 | -$42 | -$44,545 |
| Stock Issued | $81,259 | $1,287 | $2,241 | $429 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $81,218 | $1,247 | $2,199 | -$44,116 |
| Forex Effect | -$82 | $595 | $232 | -$486 |
| Net Chg. in Cash | $41,037 | $33,112 | $22,115 | -$92,528 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $297,304 | $264,192 | $242,077 | $334,605 |
| End Cash | $338,341 | $297,304 | $264,192 | $242,077 |
| Free Cash Flow | -$134,743 | $137,069 | -$163,352 | -$141,636 |